Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

J Neurooncol. 2016 Jul;128(3):417. doi: 10.1007/s11060-016-2153-6.

Shamik Chakraborty^{1

2}, Christopher G Filippi², Tamika Wong¹, Ashley Ray¹, Sherese Fralin¹, A John Tsiouris³, Bidyut Praminick², Alexis Demopoulos^{1

2}, Heather J McCrea³, Imithri Bodhinayake¹, Rafael Ortiz^{1

2}, David J Langer^{1

2}, John A Boockvar^{4

5

6}

¹ Lenox Hill Brain Tumor Center, Lenox Hill Hospital, Northwell Health, New York, NY, USA.
² Departments of Neurosurgery, Neurology, Radiology, and Pathology, Hofstra Northwell School of Medicine, Manhasset, NY, USA.
³ Departments of Neurosurgery and Radiology, Weill Cornell Medical College of Cornell University, New York, NY, USA.
⁴ Lenox Hill Brain Tumor Center, Lenox Hill Hospital, Northwell Health, New York, NY, USA. jboockvar@nshs.edu.
⁵ Departments of Neurosurgery, Neurology, Radiology, and Pathology, Hofstra Northwell School of Medicine, Manhasset, NY, USA. jboockvar@nshs.edu.
⁶ Department of Neurological Surgery, Hofstra Northwell School of Medicine, Manhasset, NY, USA. jboockvar@nshs.edu.

No abstract available

Publication types